5yxu
From Proteopedia
(Difference between revisions)
m (Protected "5yxu" [edit=sysop:move=sysop]) |
|||
(2 intermediate revisions not shown.) | |||
Line 1: | Line 1: | ||
- | '''Unreleased structure''' | ||
- | + | ==an affinity enhanced T cell receptor in complex with HLA-A0201 restricted HCV NS3 peptide KLVALGINAV== | |
- | + | <StructureSection load='5yxu' size='340' side='right' caption='[[5yxu]], [[Resolution|resolution]] 2.70Å' scene=''> | |
- | + | == Structural highlights == | |
- | + | <table><tr><td colspan='2'>[[5yxu]] is a 10 chain structure with sequence from [http://en.wikipedia.org/wiki/9hepc 9hepc] and [http://en.wikipedia.org/wiki/Human Human]. Full crystallographic information is available from [http://oca.weizmann.ac.il/oca-bin/ocashort?id=5YXU OCA]. For a <b>guided tour on the structure components</b> use [http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5YXU FirstGlance]. <br> | |
- | + | </td></tr><tr id='gene'><td class="sblockLbl"><b>[[Gene|Gene:]]</b></td><td class="sblockDat">HLA-A, HLAA ([http://www.ncbi.nlm.nih.gov/Taxonomy/Browser/wwwtax.cgi?mode=Info&srchmode=5&id=9606 HUMAN])</td></tr> | |
- | [[Category: | + | <tr id='resources'><td class="sblockLbl"><b>Resources:</b></td><td class="sblockDat"><span class='plainlinks'>[http://oca.weizmann.ac.il/oca-docs/fgij/fg.htm?mol=5yxu FirstGlance], [http://oca.weizmann.ac.il/oca-bin/ocaids?id=5yxu OCA], [http://pdbe.org/5yxu PDBe], [http://www.rcsb.org/pdb/explore.do?structureId=5yxu RCSB], [http://www.ebi.ac.uk/pdbsum/5yxu PDBsum], [http://prosat.h-its.org/prosat/prosatexe?pdbcode=5yxu ProSAT]</span></td></tr> |
+ | </table> | ||
+ | == Function == | ||
+ | [[http://www.uniprot.org/uniprot/1A02_HUMAN 1A02_HUMAN]] Involved in the presentation of foreign antigens to the immune system. | ||
+ | __TOC__ | ||
+ | </StructureSection> | ||
+ | [[Category: Human]] | ||
[[Category: Yi, L]] | [[Category: Yi, L]] | ||
+ | [[Category: Affinity enhanced tcr-phla complex]] | ||
+ | [[Category: Immune system]] |
Current revision
an affinity enhanced T cell receptor in complex with HLA-A0201 restricted HCV NS3 peptide KLVALGINAV
|